Dexcom CEO on Q2 earnings beat, providing glucose monitoring amid pandemic

Dexcom CEO Kevin Sayer joined Jim Cramer on "Mad Money" to discuss how the medical device manufacturer met quarterly expectations, despite the issues afflicting health care.